REFERENCES
- Daniel W J, Mohamed S D, Matheson N A. Treatment of mesenteric embolism with dextran 40. Lancet 1966; 1: 567–569
- Feest T G. Low molecular weight dextran: a continuing cause of acute renal failure. Br Med J 1976; 2: 1300
- Van den Berg C J, Pineda A A. Plasma exchange in the treatment of acute renal failure due to low molecular-weight dextran. Mayo Clinic Proc 1980; 55: 387–389
- Schwartz J, Ihle B, Dowling J. Acute renal failure induced by low molecular weight dextran. Aust NZ J Med 1984; 14: 688–689
- Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987; 3l7: 150–153
- Druml W, Polzleitner D, Laggner A N, Lenz K, Ulrich W. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 1988; 318: 252–253
- Zwaveling J H, Meulenbeit J, van Xanten N HW, Hene R J. Renal failure associated with the use of dextran-40. Neth J Med 1989; 35: 321–326
- Kurnik B RC, Singer F, Groh W C. Case report: dextran-induced acute anuric renal failure. Am J Med Sci 1991; 302: 28–30
- Biesenbach G, Kaiser W, Zazgornik J. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV. Ren Fail 1997; 19: 69–75
- Ferraboli R, Malheiro P S, Abdulkader R C, Yu L, Sabbaga E, Burdmann E A. Anuric acute renal failure caused by dextran 40 administration. Ren Fail 1997; 19: 303–306
- Messmer F L. Acute oligoanuric renal failure in dextran 40 treated patients. Ren Fail 1998; 20: 543–545
- Diomi P, Ericsson J LE, Matheson N A, Shearer I R. Studies on renal tubular morphology and toxicity after large doses of dextran 40 in the rabbit. Lab invest 1970; 22: 355–360
- Chinitz J L, Kim K E, Onesti G, Swartz C. Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 1971; 77: 76–87
- Mailloux L, Swartz C D, Capizzi R, Kim K E, Onesti G, Ramirez O, Brest A N. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med 1967; 277: 1113–1118